Christopher Cano

Insider Reports History

Location
Austin, TX
Signature
/s/ Christopher Cano, by Kirk Allen Coleman, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Cano:

Company Role Class Num Shares Value Price $ Report Date Ownership
TFF Pharmaceuticals, Inc. Chief Operating Officer Stock Option (Right to Buy) 200,000 22 Sep 2021 Direct

Insider Reports Filed by Christopher Cano

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000121390021049792-cano-christopher-2021-09-22 TFF Pharmaceuticals, Inc. 22 Sep 2021 1 $0 4 Chief Operating Officer 24 Sep 2021, 16:15
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .